Business | 2009.06.09
Certara Names William Cobert as Vice President of European Sales for its Tripos and Pharsight Business Units
ST. LOUIS, Mo.--(BUSINESS WIRE)--Certara™, a global, emerging translational pharmacology company, formed by the acquisition of Pharsight® Corporation by Tripos™, today announced the appointment of
For more information, please visit
http://www.businesswire.com/news/home/20090609005267/en
